Tumor-induced osteomalacia (TIO) is an ultrarare paraneoplastic syndrome due to
overproduction of fibroblast growth factor 23 (FGF23), with profound effects on patient …

Perhaps the rarest cause of osteomalacia is that caused by a neoplasm, so-called “tumor-
induced osteomalacia”(TIO). Although very rare cases of TIO have been associated with …

Patients with tumor‐induced osteomalacia (TIO), an acquired paraneoplastic condition
characterized by osteomalacia due to hypophosphatemia, exhibit a similar clinical picture to …

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome clinically
characterized by bone pain, fractures and muscle weakness. It is caused by tumoral …

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by tumoral
overproduction of FGF-23. Due to local recurrence, we describe the long-term efficacy and …

Abstract Tumor-induced osteomalacia (TIO), also known as “oncogenic osteomalacia”, is a
rare cause of osteomalacia. TIO often has an insidious onset characterized clinically by …

Purpose Tumor induced osteomalacia (TIO) is a rare disease of mineral metabolism, whose
clinical picture is dominated by hypophosphatemia usually due to an excess of circulating …

Tumor induced osteomalacia (TIO) is a chronic condition associated with muscle weakness
and long term disability. We conducted a cross sectional study of patients diagnosed with …

Tumor-induced osteomalacia in the head and neck region remains a challenging diagnosis
to manage. Literature pertaining to management and outcome details remains sparse. We …

Somatostatin receptor (SSTR) agonist tracers used in nuclear medicine scans are classically
used for neuroendocrine tumor diagnosis and staging. SSTR are however, expressed more …